Tezepelumab

ATC R03DX11 · 10 markets · 19 records

Tezepelumab 10 markets · 19 records Forms

AU 4 records · 3 strengths

  • 210 mginjectionTezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled penTezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe also in ES·TW unknown
  • 210 mg/1.91 mLinjectionTEZSPIRE also in GB

Records without a stated strength · 1 TEZSPIRE

US 2 records · 1 strengths

GB 2 records · 1 strengths

  • 210 mg/1.91 mLinjectionTezspire 210mg/1.91ml solution for injection pre-filled pensTezspire 210mg/1.91ml solution for injection pre-filled syringes also in AU

CA 2 records · 1 strengths

SG 2 records · 1 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED PEN、TEZSPIRE SOLUTION FOR INJECTION 210 MG IN PRE-FILLED SYRINGE

    ES 1 records · 1 strengths

    MX 1 records · 1 strengths

      Records without a stated strength · 1 TEZSPIRE

      TW 1 records · 1 strengths

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 TEZSPIRE

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.